• news.cision.com/
  • H. Lundbeck A/S/
  • H. Lundbeck, Lundbeck and Forest Laboratories announce Lexapro® patent litigation trial date reschedules to March 15, 2006
English

H. Lundbeck, Lundbeck and Forest Laboratories announce Lexapro® patent litigation trial date reschedules to March 15, 2006

Report this content 

                        
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, and its partner H. Lundbeck A/S of Denmark, announced that the Federal District Court, District of Delaware has today rescheduled the start of its pending patent litigations trial regarding Lexapro® (escitalopram oxalate) from December 5, 2005 to March 15, 2006. A pretrial conference has been scheduled for February 7, 2006. Forest and Lundbeck remain confident in the strength and validity of the Lexapro patent.




                                            

                

            

        

    

    



    

        
 Subscribe

        

            

        

    


        

            
        

        

            
        

        



    

        
 Documents & Links